1.1 This practice covers blood that will be used for in vitro performance assessments of blood pumps. These assessments include the hemolytic properties of the devices.
F1841-19e1
Standard Practice for Assessment of Hemolysis in Continuous Flow Blood Pumps (Includes all amendments and changes 5/26/2021).